查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423202

2024-2032 年按產品類型（生物保存設備、生物保存介質）、應用（治療應用、生物庫應用、藥物發現應用）和區域分類的生物保存市場報告

Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球生物防腐市場規模達77億美元。展望未來， IMARC Group預計到2032年市場規模將達到193億美元，2024-2032年複合年成長率（CAGR）為10.4%。大眾對個人化醫療的日益關注、研發（R&D）活動投資的增加以及對罕見疾病的認知和理解的不斷提高是推動市場的一些主要因素。

生物保存是指長時間保存生物材料（例如細胞、組織、器官或整個生物體）處於可行和功能狀態的過程。該過程的目標是保持生物材料的完整性、活力和功能性，使其能夠儲存、運輸和用於各種目的，包括研究、臨床應用和工業過程。它在各個領域都有廣泛的應用，包括醫學、生物技術以及用於儲存細胞、組織和器官以進行移植、再生醫學和藥物開發的研究。

全球市場的主要驅動力是大眾對個人化醫療的日益關注。此外，政府、學術機構和私人組織在生命科學、生物技術和醫療保健領域對研發（R&D）活動的​​投資不斷增加，也為市場提供了推動力。此外，隨著個體對罕見疾病和遺傳性疾病的認知和理解不斷提高，越來越需要保存受影響群體的生物樣本。這些技術支援收集和儲存這些樣本，用於研究疾病機制、開發診斷方法和促進標靶治療的開發，從而滿足全球的需求。此外，改進的冷凍保護劑、自動化系統和增強的儲存協議的開發正在擴大生物保存的能力和應用，因為它們有助於維持保存的生物材料的效率、可靠性和安全性，進一步創造積極的市場前景。

生物保存市場趨勢/促進因素：

對生物樣本庫的需求不斷增加

生物樣本庫需求的不斷成長對全球市場產生了重大影響。生物樣本庫是儲存各種生物樣本的儲存庫，包括細胞、組織、血液、DNA 和其他生物材料，用於研究和診斷目的。這些技術在維持這些樣本的完整性、可行性和功能性、確保其長期儲存和可用性方面發揮著至關重要的作用。對大規模人群研究、臨床試驗和研究項目的需求不斷成長，這些研究、臨床試驗和研究項目需要多樣化且保存完好的生物樣本，這正在影響全球整個生物樣本庫領域。此外，對精準醫療和個人化醫療保健的日益關注放大了生物樣本庫的重要性，因為它們提供了全面的樣本集合，可用於基因組測試、生物標記發現和客製化治療的開發。

再生醫學的不斷進步

再生醫學的進步對全球市場產生重大影響。生物保存透過保留細胞、組織和工程結構的活力和功能，在再生醫學的成功中發揮著至關重要的作用，因為再生醫學的目標是使用基於細胞的療法、組織工程和其他創新方法來恢復或替換受損的組織或器官。 。此外，這些技術對於在儲存和運輸過程中維持幹細胞的活力和效力至關重要。冷凍和玻璃化等冷凍保存方法通常用於保存幹細胞以供將來在治療或研究中使用。幹細胞保存方案和冷凍保護劑的進步增強了幹細胞的活力和解凍後功能，促進了市場的成長。

生物製藥產業的擴張

生物製藥產業的擴張是影響市場的重要因素。生物製藥產業專注於生物藥物的開發和生產，包括治療性蛋白質、抗體、疫苗和細胞療法。生物保存在確保這些複雜生物產品從開發到分銷的整個生命週期的穩定性、品質和完整性方面發揮著至關重要的作用。由於生物藥物對溫度、光線和濕度等環境條件高度敏感，對這些技術的需求大幅增加，因為它們對於維持這些藥物在儲存和運輸過程中的穩定性和品質至關重要。透過採用冷凍保存、冷凍乾燥或其他適當的保存方法，生物製藥公司可以延長其產品的保存期限，並確保其在給患者服用時的有效性和安全性。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球生物保存市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場區隔：依產品類型
  • 市場區隔：按應用
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第 6 章：市場區隔：依產品類型

  • 生物保存設備
    • 市場走向
    • 市場預測
  • 生物保存介質
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 治療應用
    • 市場走向
    • 市場預測
  • 生物樣本庫應用
    • 市場走向
    • 市場預測
  • 藥物發現應用
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 市場走向
    • 市場預測
  • 歐洲
    • 市場走向
    • 市場預測
  • 亞太地區
    • 市場走向
    • 市場預測
  • 拉丁美洲
    • 市場走向
    • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場預測

第 9 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BioLife Solutions, Inc.
    • Thermo Fisher Scientific Inc.
    • VWR International, LLC
    • Panasonic Corporation
    • BioCision LLC
Product Code: SR112024A829

Abstract

The global biopreservation market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.3 Billion by 2032, exhibiting a growth rate (CAGR) of 10.4% during 2024-2032. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.

Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.

The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.

Biopreservation Market Trends/Drivers:

Increasing Demand for Biobanking

The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.

Continual Advancements in Regenerative Medicine

Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.

The Expansion of the Biopharmaceutical Industry

The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.

Biopreservation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biopreservation market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type and application.

Breakup by Product Type:

Biopreservation Equipment

Biopreservation Media

Biopreservation equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes equipment and media. According to the report, biopreservation equipment represented the largest segment.

Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.

On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.

Breakup by Application:

Therapeutic Applications

Biobank Applications

Drug Discovery Applications

Biobank applications hold the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes therapeutic applications, biobank applications, and drug discovery applications. According to the report, biobank applications accounted for the largest market share.

Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.

On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.

Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.

On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.

Competitive Landscape:

Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

BioLife Solutions, Inc.

Thermo Fisher Scientific Inc.

VWR International, LLC

Panasonic Corporation

BioCision LLC

Recent Developments:

In June 2023, BioLife Solutions, Inc. introduced a new, large-capacity controlled-rate freezer (CRF) in order to expand its CRF product line. This new product will allow the company to support autologous and allogeneic CGT customers and its commercial-scale manufacturing as well as fulfills crucial customer needs to perform high-volume cell therapies.

In Jan 2023, Thermo Fisher Scientific Inc. completed its mergers and acquisition (M&A) agreement with The Binding Site Group ("The Binding Site"), a global leader in specialty diagnostics in order to expand its existing specialty diagnostics portfolio and include pioneering innovation in diagnostics and monitoring for multiple myeloma.

PHC Holdings Corporation announced in 2023 that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd., making SciMed a wholly owned subsidiary of PHCHD. This acquisition will assist in expanding the life sciences business of the company across the Asia-Pacific region.

Key Questions Answered in This Report

  • 1. What was the size of the global biopreservation market in 2023?
  • 2. What is the expected growth rate of the global biopreservation market during 2024-2032?
  • 3. What are the key factors driving the global biopreservation market?
  • 4. What has been the impact of COVID-19 on the global biopreservation market?
  • 5. What is the breakup of the global biopreservation market based on the product type?
  • 6. What is the breakup of the global biopreservation market based on the application?
  • 7. What are the key regions in the global biopreservation market?
  • 8. Who are the key players/companies in the global biopreservation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biopreservation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Biopreservation Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biopreservation Media
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Applications
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biobank Applications
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Discovery Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Competitive Landscape

  • 9.1 Market Structure
  • 9.2 Key Players
  • 9.3 Profiles of Key Players
    • 9.3.1 BioLife Solutions, Inc.
    • 9.3.2 Thermo Fisher Scientific Inc.
    • 9.3.3 VWR International, LLC
    • 9.3.4 Panasonic Corporation
    • 9.3.5 BioCision LLC

List of Figures

  • Figure 1: Global: Biopreservation Market: Major Drivers and Challenges
  • Figure 2: Global: Biopreservation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biopreservation Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Biopreservation Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Biopreservation Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Biopreservation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Biopreservation Industry: SWOT Analysis
  • Figure 8: Global: Biopreservation Industry: Value Chain Analysis
  • Figure 9: Global: Biopreservation Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Biopreservation Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biopreservation Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biopreservation Media Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biopreservation Media Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biopreservation (Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biopreservation (Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biopreservation (Biobank Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biopreservation (Biobank Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biopreservation (Drug Discovery Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biopreservation (Drug Discovery Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: North America: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: North America: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Europe: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Europe: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Asia Pacific: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Asia Pacific: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Latin America: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Latin America: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Biopreservation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Biopreservation Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biopreservation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Biopreservation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Biopreservation Market: Competitive Structure
  • Table 6: Global: Biopreservation Market: Key Players